News Snapshot:
Global competition for early coronavirus vaccine doses is already fierce, months ahead of any approvals, as wealthy countries move to secure supplies. The US government has pledged over US$3 billion to secure hundreds of millions of doses of vaccines under development by Britain's AstraZeneca Plc and by US drug giant Pfizer Inc and Germany's BioNTech. READ MORE: WHO: Global virus toll could hit 2m before vaccine in wide use Malpass said the World Bank plan aimed to put poor and middle-income countries, where the virus is spreading most rapidly, on the same footing as richer countries by ensuring they have...